Concentra Group Holdings Reports Strong Q1 2026 Earnings and Raises Guidance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy CON?
Source: seekingalpha
- Significant Revenue Growth: Concentra Group reported total revenue of $569.6 million in Q1 2026, reflecting strong performance in the workers' compensation sector, which is expected to further enhance overall financial health and stability.
- Increased Patient Visits: The company experienced a 6.7% increase in patient visits, averaging over 54,000 per day, indicating ongoing improvements in customer satisfaction and market share, thereby strengthening its competitive position in the healthcare services market.
- Upgraded Full-Year Outlook: CFO DiCanio raised the 2026 revenue guidance by $25 million to a range of $2.275 billion to $2.375 billion, along with an adjustment in EBITDA expectations, showcasing the company's confidence in future performance and robust market demand.
- Leadership Transition Plan: Chief Medical Officer John Anderson announced his retirement at the end of the year, prompting Concentra to evaluate both internal and external candidates to ensure a smooth leadership transition, thereby reinforcing the company's long-term strategic direction.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CON?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CON
Wall Street analysts forecast CON stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 23.600
Low
27.00
Averages
28.67
High
30.00
Current: 23.600
Low
27.00
Averages
28.67
High
30.00
About CON
Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. It delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care, to more than 53,000 patients each day, on average, from about 682 occupational health centers in 41 states and 411 onsite health clinics at employer worksites in 44 states. Its Occupational Health Centers segment encompasses the services it delivers at its occupational health center facilities across the United States. Its Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer's workplace, including mobile health services and episodic specialty testing services. Its Other Businesses segment comprises several complementary services to its core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CONCENTRA GROUP HOLDINGS PARENT, INC. REPORTS FIRST QUARTER RESULTS FOR MARCH 31, 2026, DECLARES CASH DIVIDEND, AND UPDATES FY 2026 GUIDANCE UPWARD
Company Announcement: Concentragroup Holdings Parent, Inc. has announced its financial results for the first quarter ending March 31, 2026.
Cash Dividend: The company declared a cash dividend as part of its financial results.
Guidance Update: Concentragroup Holdings has raised its guidance for the fiscal year 2026.
Financial Performance: The announcement highlights the company's performance and strategic outlook for the upcoming fiscal year.
See More
CONCENTRA GROUP HOLDINGS PARENT INC REPORTS Q1 EPS OF USD 0.39
Company Overview: Concentragroup Holdings is a parent company that operates in various sectors, with a focus on strategic investments and management.
Financial Performance: The company reported earnings per share (EPS) of $0.39 for the first quarter, indicating a positive financial outlook.
See More
CONCENTRA GROUP HOLDINGS PARENT INC REPORTS Q1 REVENUE OF USD 569.555 MILLION, BEATING IBES ESTIMATE OF USD 553.5 MILLION
Revenue Comparison: Concentragroup Holdings reported a revenue of USD 569.55 million for Q1, surpassing Ibes' estimate of USD 553.5 million.
Financial Performance: The significant difference in revenue indicates a strong financial performance by Concentragroup Holdings in the first quarter.
See More
Concentra Group Holdings Reports Strong Q1 2026 Earnings and Raises Guidance
- Significant Revenue Growth: Concentra Group reported total revenue of $569.6 million in Q1 2026, reflecting strong performance in the workers' compensation sector, which is expected to further enhance overall financial health and stability.
- Increased Patient Visits: The company experienced a 6.7% increase in patient visits, averaging over 54,000 per day, indicating ongoing improvements in customer satisfaction and market share, thereby strengthening its competitive position in the healthcare services market.
- Upgraded Full-Year Outlook: CFO DiCanio raised the 2026 revenue guidance by $25 million to a range of $2.275 billion to $2.375 billion, along with an adjustment in EBITDA expectations, showcasing the company's confidence in future performance and robust market demand.
- Leadership Transition Plan: Chief Medical Officer John Anderson announced his retirement at the end of the year, prompting Concentra to evaluate both internal and external candidates to ensure a smooth leadership transition, thereby reinforcing the company's long-term strategic direction.
See More
Concentra Group Raises 2026 Financial Guidance Following Strong Q1 Results
- Strong Performance: Concentra Group reported a Q1 non-GAAP EPS of $0.40, beating expectations by $0.06, which reflects the company's robust market performance and boosts investor confidence.
- Revenue Growth: The company achieved Q1 revenue of $569.6 million, exceeding market expectations by $16.11 million, indicating successful business expansion and strong market demand, thereby solidifying its market position.
- Guidance Upgrade: Concentra raised its 2026 revenue guidance to a range of $2.275 billion to $2.375 billion, with adjusted EBITDA expectations of $460 million to $480 million, demonstrating confidence in future growth and proactive strategic planning.
- Capital Expenditure Plans: The company plans to allocate $70 million to $80 million in capital expenditures for 2026, aimed at supporting its de novo expansion and M&A strategy, further enhancing its long-term growth potential.
See More
Concentra Group Holdings Declares Quarterly Dividend of $0.0625
- Quarterly Dividend Announcement: Concentra Group Holdings has declared a quarterly dividend of $0.0625 per share, consistent with previous payouts, indicating stable cash flow and profitability, which is likely to attract more investor interest.
- Dividend Payment Timeline: The dividend will be payable on June 9, with a record date of May 19 and an ex-dividend date also on May 19, ensuring that existing shareholders receive timely returns, thereby enhancing shareholder confidence.
- Consistent Dividend Record: Concentra has announced the same dividend for seven consecutive quarters, demonstrating the company's ability to maintain stable financial performance amid economic fluctuations, further solidifying its market position.
- Future Revenue Target: Concentra has set a revenue target of $2.25 billion to $2.35 billion for 2026, reflecting the company's proactive stance in expanding its de novo and M&A strategies, signaling potential for future growth.
See More
CONCENTRA GROUP HOLDINGS PARENT, INC. REPORTS FIRST QUARTER RESULTS FOR MARCH 31, 2026, DECLARES CASH DIVIDEND, AND UPDATES FY 2026 GUIDANCE UPWARD
Company Announcement: Concentragroup Holdings Parent, Inc. has announced its financial results for the first quarter ending March 31, 2026.
Cash Dividend: The company declared a cash dividend as part of its financial results.
Guidance Update: Concentragroup Holdings has raised its guidance for the fiscal year 2026.
Financial Performance: The announcement highlights the company's performance and strategic outlook for the upcoming fiscal year.
See More
CONCENTRA GROUP HOLDINGS PARENT INC REPORTS Q1 EPS OF USD 0.39
Company Overview: Concentragroup Holdings is a parent company that operates in various sectors, with a focus on strategic investments and management.
Financial Performance: The company reported earnings per share (EPS) of $0.39 for the first quarter, indicating a positive financial outlook.
See More
CONCENTRA GROUP HOLDINGS PARENT INC REPORTS Q1 REVENUE OF USD 569.555 MILLION, BEATING IBES ESTIMATE OF USD 553.5 MILLION
Revenue Comparison: Concentragroup Holdings reported a revenue of USD 569.55 million for Q1, surpassing Ibes' estimate of USD 553.5 million.
Financial Performance: The significant difference in revenue indicates a strong financial performance by Concentragroup Holdings in the first quarter.
See More
Concentra Group Holdings Reports Strong Q1 2026 Earnings and Raises Guidance
- Significant Revenue Growth: Concentra Group reported total revenue of $569.6 million in Q1 2026, reflecting strong performance in the workers' compensation sector, which is expected to further enhance overall financial health and stability.
- Increased Patient Visits: The company experienced a 6.7% increase in patient visits, averaging over 54,000 per day, indicating ongoing improvements in customer satisfaction and market share, thereby strengthening its competitive position in the healthcare services market.
- Upgraded Full-Year Outlook: CFO DiCanio raised the 2026 revenue guidance by $25 million to a range of $2.275 billion to $2.375 billion, along with an adjustment in EBITDA expectations, showcasing the company's confidence in future performance and robust market demand.
- Leadership Transition Plan: Chief Medical Officer John Anderson announced his retirement at the end of the year, prompting Concentra to evaluate both internal and external candidates to ensure a smooth leadership transition, thereby reinforcing the company's long-term strategic direction.
See More
Concentra Group Raises 2026 Financial Guidance Following Strong Q1 Results
- Strong Performance: Concentra Group reported a Q1 non-GAAP EPS of $0.40, beating expectations by $0.06, which reflects the company's robust market performance and boosts investor confidence.
- Revenue Growth: The company achieved Q1 revenue of $569.6 million, exceeding market expectations by $16.11 million, indicating successful business expansion and strong market demand, thereby solidifying its market position.
- Guidance Upgrade: Concentra raised its 2026 revenue guidance to a range of $2.275 billion to $2.375 billion, with adjusted EBITDA expectations of $460 million to $480 million, demonstrating confidence in future growth and proactive strategic planning.
- Capital Expenditure Plans: The company plans to allocate $70 million to $80 million in capital expenditures for 2026, aimed at supporting its de novo expansion and M&A strategy, further enhancing its long-term growth potential.
See More
Concentra Group Holdings Declares Quarterly Dividend of $0.0625
- Quarterly Dividend Announcement: Concentra Group Holdings has declared a quarterly dividend of $0.0625 per share, consistent with previous payouts, indicating stable cash flow and profitability, which is likely to attract more investor interest.
- Dividend Payment Timeline: The dividend will be payable on June 9, with a record date of May 19 and an ex-dividend date also on May 19, ensuring that existing shareholders receive timely returns, thereby enhancing shareholder confidence.
- Consistent Dividend Record: Concentra has announced the same dividend for seven consecutive quarters, demonstrating the company's ability to maintain stable financial performance amid economic fluctuations, further solidifying its market position.
- Future Revenue Target: Concentra has set a revenue target of $2.25 billion to $2.35 billion for 2026, reflecting the company's proactive stance in expanding its de novo and M&A strategies, signaling potential for future growth.
See More
